For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Automated insulin delivery: Benefits outweigh risk to eyes
+Practice
In print
Research: Diabetes
Automated insulin delivery: Benefits outweigh risk to eyes
Wednesday 26 March 2025, 12:15 AM

Younger age at initiation of automated insulin delivery protects against worsening diabetic retinopathy [Image: Halfpoint on iStock]
Automated insulin delivery is a new technology used to control diabetes that could risk diabetic retinopathy deterioration. Research done in Dunedin has now demonstrated these systems are safe for the eyes
Key Points, Rapid glycaemic control has previously been associated with early worsening of diabetic retinopathy.
New research has demonstrated stable or improve, Pract Green w Pale Yellow
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
References
Johansson MME, March de Ribot F, Sime MJ, et al. Short-term diabetic retinopathy status in people with type 1 diabetes commencing automated insulin delivery. Diabetes Technol Ther 2025: 10 February online.